People v. Davis CA3

CourtCalifornia Court of Appeal
DecidedDecember 17, 2021
DocketC092962
StatusUnpublished

This text of People v. Davis CA3 (People v. Davis CA3) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
People v. Davis CA3, (Cal. Ct. App. 2021).

Opinion

Filed 12/17/21 P. v. Davis CA3 NOT TO BE PUBLISHED California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA THIRD APPELLATE DISTRICT (Sacramento) ----

THE PEOPLE, C092962

Plaintiff and Respondent, (Super. Ct. No. 51318)

v.

JONATHAN EARL DAVIS,

Defendant and Appellant.

In 1978, defendant Jonathan Earl Davis was found not guilty by reason of insanity (NGI) of murder. Defendant appeals from the trial court’s order extending his commitment to a state hospital under Penal Code section 1026.5, subdivision (b)(1) (statutory section references that follow are to the Penal Code unless otherwise stated). He contends the state did not show that he currently presented a substantial danger of physical harm to others and suffered from a volitional impairment rendering him dangerous beyond his control. We affirm the judgment.

FACTS AND HISTORY OF THE PROCEEDINGS Defendant was committed to the state hospital in 1978 after being found NGI of murder. In May 2020, the People filed a petition to extend defendant’s NGI commitment pursuant to section 1026.5. The petition attached a recommendation and affidavit signed

1 by Dr. Carolina Klein, medical director of Napa State Hospital (NSH). Dr. Klein requested an extension of the commitment, declaring that “in his present status and condition, by reason of a mental disease, defect or disorder, [defendant] represents a substantial danger of physical harm to others.” Defendant’s court trial occurred in September 2020, after which the parties submitted briefing. Dr. Lei Wei, a psychiatrist at NSH, testified that NSH has a three-level system for classifying patients. Defendant is in the lowest level—the level for patients with the lowest ability to function and perform activities of daily living. Generally, patients in the lowest level are severely ill. Dr. Wei explained that defendant suffers from schizophrenia and is the subject of an involuntary medication order because he lacks the capacity to make medication decisions for himself. Defendant suffers from some delusional beliefs, including the belief that he did not commit the underlying offense and the belief that he is not being given real medications. Defendant also exhibits negative symptoms of schizophrenia, such as a lack of emotional response. Generally, people who have negative symptoms have pretty severe psychotic disorders. Dr. Wei did not believe that defendant would voluntarily take medications if released because he stated he does not need medications. If defendant failed to take his medications, Dr. Wei opined he would most likely relapse into a full psychotic state with hallucinations, delusions, and paranoia. Dr. Wei opined that, because of defendant’s mental disorder, he posed a substantial danger of physical harm to others and had serious difficulty controlling his dangerous behavior and posed a high risk for relapse and violence. Dr. Wei explained that when people like defendant with psychotic disorders relapse, it is typical for them to have paranoia and/or delusions such as feeling they are under God’s command. They can have auditory or visual hallucinations that tell them to hurt themselves or others. This is highly dangerous and is a predisposing factor for violence. Dr. Wei observed defendant’s condition was not in full remission, another high-risk factor that increases dangerousness.

2 Dr. Wei explained that a small percentage of patients are not fully responsive to even the most aggressive medication regimen, and she saw defendant falling into that group. Defendant takes an antipsychotic medication used to treat people who are resistant to other antipsychotic medications. Defendant had never participated in the conditional release program (CONREP) because CONREP requires patients to be in full remission, as Dr. Wei described it. Dr. Mahalet Tekeste was a psychologist at NSH, and she testified she agreed with defendant’s diagnosis of schizophrenia. Defendant exhibited three main symptoms of schizophrenia: disorganized behavior, disorganized speech, and psychotic beliefs. Despite taking medications in the hospital setting, defendant still displays symptoms of mental illness. Dr. Tekeste was concerned that if defendant stopped taking medication he might decompensate and become violent. Dr. Tekeste explained it is important for mentally ill people to be able to recognize signs of mental illness so that when they decompensate they can get help before they behave in a violent manner, but defendant has told Dr. Tekeste that he does not have a mental illness and believes there is no point in taking medication. Dr. Tekeste noted it was because of paranoid delusions that defendant committed the underlying offense of murder. Dr. Tekeste performed a violence risk assessment (HCR-20) on defendant. Dr. Tekeste concluded that defendant was a low risk for violence in the hospital but a high risk for violence in the community. Defendant lacks insight into his mental illness and he continues to present symptoms of mental illness despite taking medication and attending group therapy. Dr. Tekeste opined defendant had not acted out at the hospital because he is medicated, the hospital is highly structured, and there is a lack of daily stressors. Dr. Tekeste concluded that defendant would pose a substantial risk in the community. Defendant does not understand that he has a mental illness and he does not want to take medication. It is likely he would decompensate if not medicated. If he

3 decompensates, there is a risk of violence because he might experience symptoms similar to those he experienced at the time of the underlying offense. Dr. Tekeste opined that defendant’s schizophrenia “played a primary role” in his offense. Finally, defendant has not developed a substantial relapse prevention or release plan. Defendant testified on his own behalf. He denied committing any crime, and he specifically denied committing a murder. Defendant denied having a mental illness and admitted that he took medication simply to avoid involuntary administration. On October 22, 2020, the superior court extended defendant’s commitment for two years, to May 30, 2022. The court noted that defendant refuses to voluntarily take medication and denies committing the homicide. The court acknowledged he has been nonviolent in the recent past, but this was due to medication and the structured environment of the hospital. For example, staff administer medications and de-escalate confrontations. The court also distinguished People v. Redus (2020) 54 Cal.App.5th 998, 1002 (Redus) because there, Redus had participated in CONREP and had progressed to conditional release. In contrast, defendant here was not suitable for community release because he failed to acknowledge involvement in murder, denied he was mentally ill, and did not believe he needed medication. For these reasons, the Drs. Wei and Tekeste testified that defendant’s delusions are not in remission. The court had no faith that defendant would take medications on his own. He would be ill-prepared to report to mental health personnel any paranoid, delusional, or homicidal thoughts, as Redus was able to do. Accordingly, the court granted the petition to extend the commitment. Defendant timely appealed.

DISCUSSION Defendant contends substantial evidence did not support the trial court’s order extending his commitment.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Williams
242 Cal. App. 4th 861 (California Court of Appeal, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
People v. Davis CA3, Counsel Stack Legal Research, https://law.counselstack.com/opinion/people-v-davis-ca3-calctapp-2021.